Our advertisers

Medela AG
Solus Medical Limited
Armstrong Medical
University of Plymouth
Vygon (UK) Ltd
Intersurgical Ltd
CliniMed Limited
Inspiration Healthcare
vCreate Neonatal
Baxter Healthcare Ltd
Nutricia Ltd
Central Medical Supplies Ltd
SBK (UK) Ltd
ParAid

 

 

Volume 15/Issue 4, July 2019

PReCePT: reducing cerebral palsy through improving uptake of magnesium sulphate in preterm deliveries

Ellie Wetz


Neonatal healthcare professionals in every maternity unit in the country are working together with England’s 15 Academic Health Science Networks (AHSNs) to help improve outcomes for babies born very prematurely. Through the PReCePT (PReventing Cerebral palsy in PreTerm labour) programme, women threatened with very preterm birth at ≤30 weeks of pregnancy are offered magnesium sulphate, which has a protective effect on the preterm neonatal brain. As a result, fewer babies are likely to develop cerebral palsy, improving quality of life for preterm babies and their families.

Abbreviated: Please subscribe and log in to see the full article.

 
© Copyright of Stansted News Limited 2019. Terms & Conditions of reading. Privacy policy